MedTrace Logo

SuperSaturated Oxygen Comprehensive Observational Registry

NCT06438315 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-05-15

No results posted yet for this study

Summary

The SuperSaturated Oxygen Comprehensive Observational Registry (SSCORE) registry, a prospectively designed observational study, aims to evaluate the clinical utility, infarct size reduction, and cost-effectiveness of SSO2 Therapy versus PCI alone among patients with anterior AMI in routine clinical practice.

Conditions

  • STEMI - ST Elevation Myocardial Infarction
  • AMI

Interventions

OTHER

KCCQ

Quality of life questionnaire

OTHER

Eq5D

Eq5d quality of life questionnaire

OTHER

cMRI (Subset of patients)

cardiac MRI

Sponsors & Collaborators

  • TherOx

    lead INDUSTRY

Principal Investigators

  • William W O'Neill, MD · Henry Ford Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-13
Primary Completion
2027-03-31
Completion
2029-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06438315 on ClinicalTrials.gov